AustralianSuper Pty Ltd lowered its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 23.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 962,634 shares of the technology company’s stock after selling 293,991 shares during the period. AMETEK makes up approximately 0.8% of AustralianSuper Pty Ltd’s holdings, making the stock its 26th biggest position. AustralianSuper Pty Ltd owned approximately 0.42% of AMETEK worth $173,524,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. EdgePoint Investment Group Inc. lifted its position in AMETEK by 87.9% during the third quarter. EdgePoint Investment Group Inc. now owns 1,964,236 shares of the technology company’s stock valued at $337,279,000 after purchasing an additional 918,737 shares during the period. Meridiem Investment Management Ltd. bought a new position in shares of AMETEK during the 3rd quarter valued at $130,579,000. Principal Financial Group Inc. boosted its stake in shares of AMETEK by 72.0% in the 3rd quarter. Principal Financial Group Inc. now owns 1,680,309 shares of the technology company’s stock worth $288,526,000 after buying an additional 703,501 shares during the last quarter. D1 Capital Partners L.P. bought a new stake in shares of AMETEK in the third quarter worth $79,782,000. Finally, Assenagon Asset Management S.A. increased its position in AMETEK by 434.5% during the fourth quarter. Assenagon Asset Management S.A. now owns 541,517 shares of the technology company’s stock valued at $97,614,000 after acquiring an additional 440,197 shares during the last quarter. Hedge funds and other institutional investors own 87.43% of the company’s stock.
Insiders Place Their Bets
In related news, insider Tony J. Ciampitti sold 16,210 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $197.01, for a total transaction of $3,193,532.10. Following the sale, the insider now owns 49,490 shares of the company’s stock, valued at $9,750,024.90. This represents a 24.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Emanuela Speranza sold 6,747 shares of AMETEK stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total value of $1,321,737.30. Following the completion of the transaction, the insider now owns 30,460 shares of the company’s stock, valued at approximately $5,967,114. This represents a 18.13 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on AME
AMETEK Stock Performance
NYSE AME opened at $184.57 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.24 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a twelve month low of $149.03 and a twelve month high of $198.33. The business has a 50-day moving average price of $183.54 and a 200-day moving average price of $177.11. The firm has a market cap of $42.69 billion, a price-to-earnings ratio of 31.13, a price-to-earnings-growth ratio of 2.68 and a beta of 1.16.
AMETEK (NYSE:AME – Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.02. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.82 billion. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The firm’s revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.68 EPS. As a group, equities research analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK declared that its board has approved a stock repurchase program on Friday, February 7th that permits the company to buyback $1.25 billion in shares. This buyback authorization permits the technology company to repurchase up to 2.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.
AMETEK Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be issued a $0.31 dividend. This is an increase from AMETEK’s previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Friday, March 14th. AMETEK’s payout ratio is currently 18.89%.
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Read More
- Five stocks we like better than AMETEK
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Vertiv Stock Under Pressure: Is Opportunity Knocking?
- Want to Profit on the Downtrend? Downtrends, Explained.
- MicroStrategy’s 8% Preferred Stock: What Investors Should Know
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Biotechs on the Brink: 2 Stocks With Huge Potential
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.